The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
The FDA approved the first interchangeable biosimilar product, Mylan’s Semglee (insulin glargine-yfgn). Semglee (insulin glargine-yfgn) is both ...
read more
The U.S. FDA revised the Emergency Use Authorization (EUA) for baricitinib (sold under the brand name Olumiant) now authorizing baricitinib alone for ...
read more
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies ...
read more
KeifeRx, LLC, an emerging clinical-stage biotechnology company specializing in the discovery and development of new treatment options for ...
read more
MindMed, a biotech company developing psychedelic-inspired therapies, announced that it will participate in and financially support the Digital ...
read more
Novartis announced that the U.S. FDA determined that OAV-101 intrathecal (IT) clinical trials for spinal muscular atrophy (SMA) patients may proceed, ...
read more
AstraZeneca’s Saphnelo (anifrolumab-fnia) has been approved in the US for the treatment of adult patients with moderate to severe systemic lupus ...
read more
Wednesday, August 04, 2021
BioDelivery Sciences International Inc., a growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic ...
read more
Thursday, August 05, 2021
Kite, a Gilead Company, and Appia Bio, Inc., an early-stage biotechnology company developing engineered allogeneic cell therapies from hematopoietic ...
read more
Thursday, August 05, 2021
MyMD Pharmaceuticals Inc., a clinical-stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic ...
read more
Thursday, August 05, 2021
Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced that the first participants have been dosed in a Phase ...
read more
The US FDA has approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of age and older with late-onset ...
read more
Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced that the first participants have been dosed in a Phase ...
read more
AstraZeneca’s Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in the European Union (EU) for the ...
read more
Q BioMed Inc., a commercial-stage biotech company, announced that it recently entered into an exclusive distribution agreement with isoSolutions ...
read more